Consistent with our findings and hypothesis, GB1107 increased tumor M1 macrophage polarization and CD8+ T cell infiltration and potentiated the effects of a PD-L1 immune checkpoint inhibitor (48). This evidence concerns the gene CD8A and neoplasm.